Black Ridge (BRAC) Gets a Third $5M Backstop
by Kristi Marvin on 2019-07-19 at 9:54am

As expected, Black Ridge Acquisition Corp. (BRAC), is still busy rounding up backstops ahead of the closing of their business combination with Allied Esports.  To that end, BRAC announced this morning that they have entered into a Share Purchase Agreement for another $5 million.  This is in addition to their previous $5 million backstop with Simon Equity Development and their  $5 million backstop with TV Azteca. This new Share Purchase Agreement is with Lyle Berman, who is a director of BRAC, and Morris Goldfarb, a stockholder of the sponsor founder shares, which they define as “BROG”, but not to be confused with the symbol for Twelve Seas, which is also “BROG”.

Per the agreement, Mr. Berman has agreed to purchase $3,000,000 of shares of BRAC common stock and Mr. Goldfarb with purchase $2,000,000.  These open market or privately negotiated transactions will begin two days from now (it doesn’t say “business days, so let’s assume that means Monday) and will end on the close of business on Friday, July 26, 2019.

The price at which they will purchase the shares will not be greater than $10.30, which is the the amount currently held in trust.  If Mr. Berman and Mr. Goldfarb are unable to purchase the full $5,000,000 of shares, BRAC will sell to them newly issued shares upon closing of the Business Combination at the Maximum Price equal to the difference between $5,000,000 and the dollar amount of shares purchased by them.

So what do Mr. Berman and Mr. Goldfarb get for these purchases?  Well, it’s sort of similar to the their other two backstops, but a little sweeter.  In summary:

  • 1.5 additional shares of Black Ridge common stock for every ten (10) shares that are purchased, or 15% of a share.
  • BROG (BRAC’s sponsor) will transfer to them an aggregate of 200,000 shares of BRAC common stock owned by BROG.

For reference, the terms of the previous two backstops were as the following:

  • one additional share of Black Ridge common stock for every ten (10) shares that are purchased, or 1/10 of a share.
  • one warrant to purchase one (1) share of Black Ridge common stock for every two (2) shares purchased. The terms are the same as the public warrants.

All told, Black Ridge now has $15 million in backstops, but we still don’t have a new date for the shareholder vote.  The clock runs out on August 10th, so a new date should be set any day now.

Stay tuned for any further updates.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved